RecruitingPhase 3NCT07185009
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Sanofi
Maspeth, NY · New York, NY · +34 more sites
Ulcerative Colitis clinical trials in New York, NY
26 recruiting ulcerative colitis studies with a site in New York, NY.
RecruitingPhase 2NCT07697456
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Sponsor: AbbVie
New York, NY · +59 more sites
RecruitingPhase 4NCT06581328
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Sponsor: Takeda
Carmel, NY · Cedarhurst, NY · Elmhurst, NY · +98 more sites
RecruitingPhase 3NCT07577856
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Janssen Research & Development, LLC
New York, NY · +23 more sites
RecruitingPhase 3NCT06405087
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Sponsor: Takeda
New York, NY · +12 more sites
RecruitingPhase not listedNCT06750731
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
Sponsor: Mercy Medical Center
New York, NY · +5 more sites
RecruitingPhase 3NCT04844606
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Sponsor: Eli Lilly and Company
New York, NY · +10 more sites
RecruitingPhase 3NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Sponsor: Eli Lilly and Company
New York, NY · Yonkers, NY · +34 more sites
RecruitingPhase 2NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Sponsor: Spyre Therapeutics, Inc.
New York, NY · +25 more sites
RecruitingPhase 3NCT07158242
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
Sponsor: Hoffmann-La Roche
Lake Success, NY · New York, NY · +6 more sites
RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Mineola, NY · New York, NY · +48 more sites
RecruitingPhase 3NCT06651281
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Sponsor: Merck Sharp & Dohme LLC
New York, NY · +11 more sites
RecruitingPhase 3NCT07196748
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Janssen Research & Development, LLC
Carmel, NY · New York, NY · +53 more sites
RecruitingPhase 2 / Phase 3NCT05076175
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Sponsor: Bristol-Myers Squibb
New York, NY · +33 more sites
RecruitingPhase 4NCT06095128
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Sponsor: Takeda
New York, NY · +35 more sites
RecruitingPhase 2NCT07470879
A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
Sponsor: Pfizer
New York, NY · +4 more sites
RecruitingPhase 2NCT06636656
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Sponsor: Boehringer Ingelheim
New York, NY · +13 more sites
RecruitingPhase 3NCT07184996
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Sanofi
Maspeth, NY · New York, NY · +115 more sites
RecruitingNot applicableNCT05230173
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Sponsor: Mayo Clinic
Burnt Hills, NY · New York, NY · +21 more sites
RecruitingNot applicableNCT06571669
BOOM-IBD2 Pivotal Clinical Trial
Sponsor: Boomerang Medical
Manhasset, NY · New York, NY · +17 more sites
RecruitingPhase not listedNCT07237516
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
Sponsor: University of North Carolina, Chapel Hill
New York, NY · +10 more sites
RecruitingPhase 3NCT06100289
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Sponsor: Takeda
New York, NY · +13 more sites
RecruitingPhase not listedNCT06398626
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Sponsor: Pfizer
New York, NY · +26 more sites
RecruitingPhase 2NCT07113522
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Sponsor: Mirador Therapeutics, Inc.
New York, NY · Rochester, NY · +44 more sites
RecruitingNot applicableNCT05987852
Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
Sponsor: Northwestern University
New York, NY · Syracuse, NY · +11 more sites
Not yet recruitingPhase 4NCT07665294
Combination CurQD and Vedolizumab in Ulcerative Colitis
Sponsor: Ryan C Ungaro
New York, NY
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.